Kern S E, Kinzler K W, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231.
Science. 1991 Jun 21;252(5013):1708-11. doi: 10.1126/science.2047879.
The tumor-suppressor gene p53 is altered by missense mutation in numerous human malignancies. However, the biochemical properties of p53 and the effect of mutation on these properties are unclear. A human DNA sequence was identified that binds specifically to wild-type human p53 protein in vitro. As few as 33 base pairs were sufficient to confer specific binding. Certain guanines within this 33-base pair region were critical, as methylation of these guanines or their substitution with thymine-abrogated binding. Human p53 proteins containing either of two missense mutations commonly found in human tumors were unable to bind significantly to this sequence. These data suggest that a function of p53 may be mediated by its ability to bind to specific DNA sequences in the human genome, and that this activity is altered by mutations that occur in human tumors.
肿瘤抑制基因p53在众多人类恶性肿瘤中因错义突变而发生改变。然而,p53的生化特性以及突变对这些特性的影响尚不清楚。在体外鉴定出一种能与野生型人类p53蛋白特异性结合的人类DNA序列。仅33个碱基对就足以实现特异性结合。该33碱基对区域内的某些鸟嘌呤至关重要,因为这些鸟嘌呤的甲基化或被胸腺嘧啶取代会消除结合。含有在人类肿瘤中常见的两种错义突变之一的人类p53蛋白无法与该序列显著结合。这些数据表明,p53的一种功能可能是由其与人类基因组中特定DNA序列结合的能力介导的,并且这种活性会因人类肿瘤中发生的突变而改变。